Brief: Celadon Pharma Reports HY Operating Loss £2.3 Million

Celadon Pharmaceuticals

30/09/2024 07:37

Sept 30 (Reuters) - Celadon Pharmaceuticals PLC  CEL.L :
    * CELADON PHARMA - HY REVENUE £63K (30 JUNE 2023: £8K);
OPERATING
LOSS £2.3 MILLION (30 JUNE 2023: £3.2 MILLION)

Source text for Eikon:  ID:nRSd1244Ga 
Further company coverage:  CEL.L 

 ((Reuters.Briefs@thomsonreuters.com;))